{"id":2530,"date":"2007-05-04T00:13:18","date_gmt":"2007-05-03T23:13:18","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=2530"},"modified":"2013-09-20T17:09:08","modified_gmt":"2013-09-20T17:09:08","slug":"brazil-issues-plans-to-produce-generic-efavirenz","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/2530","title":{"rendered":"Brazil issues plans to produce generic efavirenz"},"content":{"rendered":"<p><strong>Brazilian Health Minister Jose Gomes Temporao signed a decree declaring that the country would purchase a generic version of Merck\u0092s antiretroviral efavirenz from an India-based generic manufacturer if the company does not offer the drug at a lower price.<\/strong><\/p>\n<p>In November 2006, Brazil and Merck began negotiations over the price of efavirenz. Brazil called on Merck to provide the drug at 65 cents per 600 mg dose &#8212; the same price the company charges the Thai government. At the time, Brazil was paying $1.59 per dose.<\/p>\n<p><a href=\"http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44508\">http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44508<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Brazilian Health Minister Jose Gomes Temporao signed a decree declaring that the country would purchase a generic version of Merck\u0092s antiretroviral efavirenz from an India-based generic manufacturer if the company does not offer the drug at a lower price. In &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-2530","post","type-post","status-publish","format-standard","hentry","category-treatment-access"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/2530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=2530"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/2530\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=2530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=2530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=2530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}